Co-Diagnostics develops innovativePCR solutions for detection of infectious disease, and liquid biopsy for detection of rare alleles associated with cancer. Our proprietary CoPrimer technology excels in disease detection, multiplexing, and life-sciences research through enhanced detection of genetic material. Our At-Home and Point-of-Care platform is designed to provide fast, inexpensive, and accurate PCR test results, utilizing proprietary chemistry and instrumentation.